Insider Trading activities of Teva Pharmaceutical Industries Ltd insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Teva Pharmaceutical Industries Ltd since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Teva Pharmaceutical Industries Ltd since year 2005. Table 2 shows the detailed insider transactions of Teva Pharmaceutical Industries Ltd since 2005. The reporting company's ticker symbol is TEVA. The reporting company's CIK number is 818686.
The total value of stock buying since 2005 is $14,432,750.
The total value of stock sales since 2005 is $397,538.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Teva Pharmaceutical Industries Ltd (TEVA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2018-05 750,000 $14,432,750 0 $0 0 $0
2018-03 0 $0 15,908 $298,156 29,289 $0
2018-02 0 $0 5,050 $99,382 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Teva Pharmaceutical Industries Ltd insiders (TEVA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2018-05-10 Mignone Roberto (Director) Buy 250,000 19.32 4,829,750
2018-05-09 Mignone Roberto (Director) Buy 500,000 19.21 9,603,000
2018-03-19 O'grady Brendan P. (EVP, North America Commercial) Sale 1,179 17.88 21,078
2018-03-19 Daniell Richard (Exec. VP, European Commercial) Sale 1,297 17.89 23,205
2018-03-19 Dethlefs Sven (EVP Global Marketing&Portfolio) Sale 571 17.88 10,208
2018-03-19 Nazzi Gianfranco (EVP, Growth Markets Commercial) Sale 457 17.89 8,176
2018-03-19 Stark David Matthew (Exec. VP Chief Legal Officer) Sale 2,358 18.38 43,340
2018-03-19 Mcclellan Michael James (EVP, Chief Financial Officer) Sale 287 17.88 5,130
2018-03-19 Griffin Deborah A (Chief Accounting Officer) Sale 943 17.88 16,858
2018-03-19 Fridriksdottir Hafrun (Executive VP, Global R&D) Sale 348 17.88 6,221
2018-03-17 O'grady Brendan P. (EVP, North America Commercial) Option Ex 1,179 .00 0
2018-03-17 Daniell Richard (Exec. VP, European Commercial) Option Ex 1,297 .00 0
2018-03-17 Dethlefs Sven (EVP Global Marketing&Portfolio) Option Ex 1,179 .00 0
2018-03-17 Nazzi Gianfranco (EVP, Growth Markets Commercial) Option Ex 872 .00 0
2018-03-17 Stark David Matthew (Exec. VP Chief Legal Officer) Option Ex 2,358 .00 0
2018-03-17 Mcclellan Michael James (EVP, Chief Financial Officer) Option Ex 660 .00 0
2018-03-17 Griffin Deborah A (Chief Accounting Officer) Option Ex 943 .00 0
2018-03-17 Fridriksdottir Hafrun (Executive VP, Global R&D) Option Ex 1,012 .00 0
2018-03-12 O'grady Brendan P. (EVP, North America Commercial) Sale 738 19.49 14,382
2018-03-12 O'grady Brendan P. (EVP, North America Commercial) Option Ex 738 .00 0
2018-03-12 Daniell Richard (Exec. VP, European Commercial) Sale 714 19.50 13,921
2018-03-12 Daniell Richard (Exec. VP, European Commercial) Option Ex 714 .00 0
2018-03-12 Dethlefs Sven (EVP Global Marketing&Portfolio) Sale 576 19.49 11,225
2018-03-12 Dethlefs Sven (EVP Global Marketing&Portfolio) Option Ex 1,190 .00 0
2018-03-12 Nazzi Gianfranco (EVP, Growth Markets Commercial) Sale 461 19.50 8,988
2018-03-12 Nazzi Gianfranco (EVP, Growth Markets Commercial) Option Ex 880 .00 0
2018-03-12 Stark David Matthew (Exec. VP Chief Legal Officer) Sale 2,441 19.20 46,867
2018-03-12 Stark David Matthew (Exec. VP Chief Legal Officer) Option Ex 2,441 .00 0
2018-03-12 Griffin Deborah A (Chief Accounting Officer) Sale 952 19.49 18,553
2018-03-12 Griffin Deborah A (Chief Accounting Officer) Option Ex 952 .00 0
2018-03-05 O'grady Brendan P. (EVP, North America Commercial) Sale 705 19.38 13,662
2018-03-05 Daniell Richard (Exec. VP, European Commercial) Sale 1,108 19.28 21,362
2018-03-05 Griffin Deborah A (Chief Accounting Officer) Sale 773 19.38 14,980
2018-03-05 Fridriksdottir Hafrun (Executive VP, Global R&D) Option Ex 3,432 .00 0
2018-03-04 Fridriksdottir Hafrun (Executive VP, Global R&D) Option Ex 1,165 .00 0
2018-03-03 O'grady Brendan P. (EVP, North America Commercial) Option Ex 1,166 .00 0
2018-03-03 Daniell Richard (Exec. VP, European Commercial) Option Ex 2,098 .00 0
2018-03-03 Dethlefs Sven (EVP Global Marketing&Portfolio) Option Ex 1,399 .00 0
2018-03-03 Nazzi Gianfranco (EVP, Growth Markets Commercial) Option Ex 1,399 .00 0
2018-03-03 Mcclellan Michael James (EVP, Chief Financial Officer) Option Ex 1,049 .00 0
2018-03-03 Griffin Deborah A (Chief Accounting Officer) Option Ex 1,166 .00 0
2018-02-15 Sabag Mark (EVP, Global Human Resources) Sale 3,000 20.52 61,560
2018-02-14 Sabag Mark (EVP, Global Human Resources) Sale 2,050 18.45 37,822

Insider trading activities including stock purchases, stock sales, and option exercises of TEVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Teva Pharmaceutical Industries Ltd (symbol TEVA, CIK number 818686) see the Securities and Exchange Commission (SEC) website.